Á lódáil...
Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Immune targeting of B-cell malignancies using chimeric antigen receptors (CARs) is a promising new approach, but critical factors impacting CAR efficacy remain unclear. To test the suitability of targeting CD22 on precursor B-cell acute lymphoblastic leukemia (BCP-ALL), lymphoblasts from 111 patient...
Na minha lista:
Main Authors: | , , , , , , , , , , , , |
---|---|
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
American Society of Hematology
2013
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3575759/ https://ncbi.nlm.nih.gov/pubmed/23243285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-06-438002 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|